Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc.（ARCT）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · ARCT · 截至 2026年6月9日
活动摘要
买入笔数
2
P-Purchase only
卖出笔数
1
近12个月
买卖比
2.00
Buy/Sell (by trades)
整体情绪
Arcturus Therapeutics Holdings Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
ARCT 季度内部人买卖趋势
ARCT 内幕交易卖出 · ARCT 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · ARCT CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
ARCT 高管卖出股份 · ARCT 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Aug 15, 2025 | SASSINE ANDY CFO · Director | Purchase | 1,238 | $20K | Form 4 |
| Oct 15, 2024 | Chivukula Pad Chief Scientific Officer & COO | Sale | 12,000 | $249K | Form 4 |
| Jun 14, 2024 | Marantz Jing L. Director | Option | 3,131 | — | Form 4 |
| Jun 14, 2024 | HOLMES EDWARD W Director | Option | 3,131 | — | Form 4 |
| Jun 14, 2024 | Markels John Director | Option | 3,131 | — | Form 4 |
| Jun 14, 2024 | Marquet Magda Director | Option | 3,131 | — | Form 4 |
| Jun 14, 2024 | BARLOW JAMES F Director | Option | 3,131 | — | Form 4 |
| Jun 14, 2024 | FARRELL PETER C Director | Option | 3,131 | — | Form 4 |
| Jun 12, 2024 | SASSINE ANDY CFO · Director | Sale | 50,000 | $1.60M⚡ | Form 4 |
| Jun 5, 2024 | Chivukula Pad Chief Scientific Officer & COO | Sale | 114 | $5K | Form 4 |
| Jun 3, 2024 | Chivukula Pad Chief Scientific Officer & COO | Sale | 26,000 | $1.04M⚡ | Form 4 |
| Mar 25, 2024 | Chivukula Pad Chief Scientific Officer & COO | Sale | 17,435 | $611K | Form 4 |
| Mar 19, 2024 | Chivukula Pad Chief Scientific Officer & COO | Sale | 8,565 | $300K | Form 4 |
| Nov 1, 2023 | Chivukula Pad Chief Scientific Officer & COO | Sale | 5,000 | $94K | Form 4 |
| Oct 2, 2023 | Chivukula Pad Chief Scientific Officer & COO | Sale | 5,000 | $128K | Form 4 |
| Sep 1, 2023 | Chivukula Pad Chief Scientific Officer & COO | Sale | 5,000 | $157K | Form 4 |
| Aug 15, 2023 | SASSINE ANDY CFO · Director | Award | 1,223 | $21K | Form 4 |
| Aug 1, 2023 | Chivukula Pad Chief Scientific Officer & COO | Sale | 5,000 | $175K | Form 4 |
| Jul 14, 2023 | Chivukula Pad Chief Scientific Officer & COO | Sale | 25,000 | $875K | Form 4 |
| Jul 14, 2023 | Kummerfeld Keith C See Remarks | Option | 1,031 | $15K | Form 4 |
| Jul 14, 2023 | Kummerfeld Keith C See Remarks | Option | 1,437 | $7K | Form 4 |
| Jul 14, 2023 | Kummerfeld Keith C See Remarks | Option | 4,500 | $41K | Form 4 |
| Jul 14, 2023 | Kummerfeld Keith C See Remarks | Sale | 6,968 | $244K | Form 4 |
| Jul 3, 2023 | Chivukula Pad Chief Scientific Officer & COO | Sale | 5,000 | $144K | Form 4 |
| Jun 1, 2023 | Chivukula Pad Chief Scientific Officer & COO | Sale | 5,000 | $136K | Form 4 |
Chivukula Pad
Chief Scientific Officer & COO
日期
Oct 15
股数
12,000
均价
$20.76
总金额
$249K
Chivukula Pad
Chief Scientific Officer & COO
日期
Jun 3
股数
26,000
均价
$40.01
总金额
$1.04M ⚡
Chivukula Pad
Chief Scientific Officer & COO
日期
Mar 25
股数
17,435
均价
$35.02
总金额
$611K
Chivukula Pad
Chief Scientific Officer & COO
日期
Mar 19
股数
8,565
均价
$35.01
总金额
$300K
Chivukula Pad
Chief Scientific Officer & COO
日期
Jul 14
股数
25,000
均价
$35.01
总金额
$875K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 ARCT 内幕交易
ARCT 内幕交易
Arcturus Therapeutics Holdings Inc.（ARCT）内幕交易数据来源于公司内部人（包括SASSINE ANDY (CFO · Director)）提交的SEC Form 4申报文件。过去12个月内，1位内部人向SEC提交了交易申报。ARCT内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Arcturus Therapeutics Holdings Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
ARCT 内幕交易 · 5个问题Arcturus Therapeutics Holdings Inc.（ARCT）的内部人包括高管和董事，如SASSINE ANDY (CFO · Director)等。过去12个月内，1位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026